Princess Margaret Cancer Centre hosts the

Applied Cancer
     
Genomics Symposium

Welcome to the Applied Cancer Genomics Symposium

The Applied Cancer Genomics Symposium is an annual key educational event organized by the Cancer Genomics Program (CGP) at the Princess Margaret Cancer Centre. The objective of the symposium is to provide the latest updates on how genomic profiling technologies can be applied to identify clinically actionable somatic point mutations and other genomic alterations (e.g., translocations, copy number abnormalities). Participants will learn about novel diagnostic approaches using next generation sequencing for tumor profiling in clinical molecular diagnostics labs, methods of bioinformatics analysis for support of tumor profiling and genotype-phenotype analysis. Opportunities for genomically-informed personalized cancer treatment in molecularly targeted and immune-based therapeutics will be emphasized. The symposium will also highlight emerging genomic technologies, including circulating tumor DNA, single cell DNA and RNA sequencing, epigenetics and transcriptome analysis. This second annual Applied Cancer Genomics Symposium follows last year's inaugural event, which was a well-attended inter-professional conference with over 200 attendees and received favorable feedback from healthcare, research and industry participants. For the 2015 Applied Cancer Genomics Symposium, both local and international expertise will be showcased. Confirmed faculty includes world class experts in clinical genetics, molecular diagnostics, omics-based technologies, bioinformatics, pathology, and genomic based clinical trials.

This one-day symposium will be held at the MaRS Discovery District in downtown Toronto:

MaRS Discovery District
101 College Street,
Toronto, ON 
M5G 1L7

http://www.marsdd.com/contact/map-directions/

 

Confirmed international speakers include:

Michael F. Berger, Ph.D. Assistant Professor, Department of Pathology, Memorial Sloan Kettering Cancer Center

Patricia M. LoRusso, D.O. Professor of Medicine, Yale Cancer Center

Rajyalakshmi Luthra, Ph.D. Professor, Hematopathology, University of Texas, M.D. Anderson Cancer Centre

Shashikant Kulkarni, MS, Ph.D., FACMG Associate Professor of Pediatrics, Genetics, Pathology and Immunology, Washington University School of Medicine

Allison W. Kurian, M.D., M.Sc. Assistant Professor of Medicine and of Health Research and Policy, Stanford University School of Medicine

John Quackenbush, Ph.D. Professor of Computational Biology and Bioinformatics, Dana Farber Cancer Institute

Target Audience for the 2015 Applied Cancer Genomics Symposium:

  • Oncologists: Medical, Radiation, Surgical
  • Pathologists
  • Clinical Geneticists
  • Genetic Councillors
  • Laboratory Directors
  • Laboratory Technicians
  • Laboratory Vendors
  • Oncology Nurses
  • Bioinformaticians
  • Basic and Translational Scientists
  • Basic, Translational and Clinical Trainees
  • Pharmaceutical Representatives

Topics to be discussed in a presentation or panel include:

  • Genomic Sequencing in Cancer, Beyond Next-Gen
  • Clinical Applications of Genomics
  • Using Genomic Sequencing to Identify Responders to Targeted and Immune Therapeutics
  • Emerging Genomic and Transcriptomic Technologies
  • Novel methods for Bioinformatics Analyses
  • Future Directions of Precision Cancer Medicine

registration form       hotel information